PE and diabetes related mortality have increased significantly from 1999 to 2024, with disproportionate burden in males, rural and Southern populations, and the need for improved cardiometabolic risk stratification and equitable access to healthcare in vulnerable populations is emphasized.
Faizan E. Mustafa, S. H. Shahab, S. Naqvi et al.· Journal of Diabetes and Meta...· 0 citations
OBJECTIVES
NSCLC is the leading cause of cancer-related mortality. While combined therapy including savolitinib and osimertinib appears promising, there exists a lack of comprehensive pooled evidence regarding its anti-oncological activity.
The objective of this study is to evaluate the efficacy and safety of combined...
Eshal Amir, M. W. Khan, M. S. Mannan et al.· American Journal of Clinical...· 0 citations
China's growing influence has fueled the discussion on the future of the Liberal International Order (LIO) while at the same time raising doubts about China's interaction with the current order. This article concentrates on the central puzzle: How to measure China's cooperation with and reform of the Liberal Internatio...
M. Shahzaib, Anwar Ali, M. Azhar· Journal of Climate and Commu...· 0 citations
LAAC provides similar overall efficacy and safety compared with medical therapy for stroke prevention in AF but should currently remain reserved for selected patients rather than replacing oral anticoagulation broadly, indicating current evidence remains underpowered and additional randomized trials are needed.
A. AL-Janabi, A. Al-shammari, A. Hageen et al.· Cardiovascular Electrophysio...· 0 citations
Baxdrostat 1 mg and 2 mg significantly increased overall adverse events and hyperkalemia, whereas serious adverse events were not significantly increased, and both higher doses significantly increased hyperkalemia risk.
M. Shahzaib, Hafsa Ali, Muhammad Roshaan et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
Findings support individualized use of rivaroxaban-based therapy in carefully selected patients, balancing ischemic and limb-protective benefits against bleeding risk, and support individualized use of rivaroxaban-based therapy in carefully selected patients.
M. Shahzaib, Muhammad Roshaan, M. K. Buhadur Ali et al.· Annals of Vascular Surgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
